Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $43.6 million versus the consensus estimate of $40.72 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.